MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

3.080 -0.230 (-6.95%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 Next >
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
From Centogene NV
Via GlobeNewswire
3 Growth Stocks to Buy at 52-Week Lows
Looking for some compelling bargains? It's time to add these three growth stocks at 52-week lows to your watchlist. 
Via InvestorPlace
Bayer and Evotec Collaborate to Advance Precision Cardiology
Via ACCESSWIRE
Crude Oil Moves Lower; B. Riley Financial Shares Jump
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Evotec SE: Invitation to Conference Call
Via ACCESSWIRE
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
 
Via Benzinga
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
 
Via Benzinga
Topics Stocks
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
 
Via Benzinga
Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
Evotec undergoes a strategic shift for sustainable growth in 2024. Priority reset to optimize operations; expect double-digit revenue growth & EBITDA improvement. New CEO appointed. Guidance and... 
Via Benzinga
Why Is Fabrinet (FN) Stock Down Today?
Fabrinet stock is falling on Wednesday after the company provided FN investors with a date for its upcoming earnings report. 
Via InvestorPlace
Why Is Evotec (EVO) Stock Down 33% Today?
Evotec stock is falling on Wednesday as EVO investors react to a lackluster 2024 revenue guidance in its 2023 earnings results. 
Via InvestorPlace
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning! 
Via InvestorPlace
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth
Via ACCESSWIRE
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Via ACCESSWIRE
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
Via ACCESSWIRE
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
Via ACCESSWIRE
Evotec welcomes Aurélie Dalbiez as Chief People Officer
Via ACCESSWIRE
Finding the Next Big Winners: 7 Stocks You Can Snag for Under $10
Looking for stocks under $10? Here are seven great bargain picks that you can buy for less than $10 per share today. 
Via InvestorPlace
3 Stocks Set to Double: Your Fast Track to 2024 Gains
Looking for bargains in the market right now? These three stocks could be set to double in coming months. 
Via InvestorPlace
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
Via ACCESSWIRE
7 Stable Stocks to Buy for 100% Returns by 2025
If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks. 
Via InvestorPlace
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today. 
Via InvestorPlace
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
Via ACCESSWIRE
What's Going On With Life Science Company Evotec Stock Today?
Evotec SE (NASDAQ: EVO) joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify novel therapies for inflammatory bowel disease (IBD). 
Via Benzinga
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
Via ACCESSWIRE
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story